Development of an inflammation-inducible gene expression system using helper-dependent adenoviral vectors
✍ Scribed by Tianyao Yang; Rongqi Duan; Huibi Cao; Benjamin H. Lee; Chun Xia; Zhijie Chang; A. Keith Tanswell; Jim Hu
- Book ID
- 102340757
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 393 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1099-498X
- DOI
- 10.1002/jgm.1501
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Clinical studies have shown that gene therapy is a promising approach for treating such genetic diseases as the eye disease, Leber's congenital amaurosis. Development of gene therapy approaches for treating chronic inflammatory diseases is, however, more challenging because it requires the production of anti‐inflammatory molecules at the diseased tissues only when they are needed.
Methods
We designed such a system by modifying the human interleukin (IL)‐6 gene promoter to direct transgene expression and delivered the system into cultured cells as well as mouse lungs using a helper‐dependent adenoviral vector.
Results
We have demonstrated both in vitro and in vivo that the reporter LacZ or human IL‐10 gene can be induced by inflammatory stimuli.
Conclusions
The results obtained indicate that the inflammation inducible gene expression system based on the modified human IL‐6 gene promoter has the potential to be used for developing gene therapy for treating inflammatory diseases. Copyright © 2010 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract ## Background A paucity of coxsackie adenovirus receptor (CAR) hampers the adenovirus serotype 5 (Ad5)‐based vector‐mediated gene transfer into malignant hematopoietic cells. Fiber‐retargeted adenoviral vectors with species B tropism can potentially bypass the CAR requirement and facil
## Abstract ## Background The helper‐dependent adenovirus (HDAd) vector is less immunogenic and has a larger cloning capacity of up to 37 kb enough to carry the full‐length dystrophin cDNA. However, high and long‐term expression of dystrophin transduced to mature muscle still remains difficult. On